J. Goldman & CO LP Gilead Sciences, Inc. Call Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $6.32 Million - $7.29 Million
100,000 New
100,000 $6.86 Million
Q4 2023

Feb 14, 2024
BUY
$73.27 - $83.09 $1.93 Million - $2.19 Million
26,300 New
26,300 $2.13 Million
Q2 2023

Aug 14, 2023
BUY
$76.01 - $86.7 $3.99 Million - $4.55 Million
52,500 New
52,500 $4.05 Million
Q4 2022

Feb 14, 2023
BUY
$62.32 - $89.47 $3.12 Million - $4.47 Million
50,000 New
50,000 $4.29 Million

Others Institutions Holding GILD

# of Institutions
1,931
Shares Held
991M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email